| Literature DB >> 33288837 |
Serena Busti1, Barbara Rossi2, Enrico Volpe1, Sara Ciulli1, Andrea Piva1,2, Federica D'Amico3, Matteo Soverini3, Marco Candela3, Pier Paolo Gatta1, Alessio Bonaldo4, Ester Grilli1, Luca Parma1.
Abstract
A 71-day study was conducted to explore the effect of increasing dietary levels (0, 250, 500, 1000 mg kg feed-1; D0, D250, D500 and D1000, respectively) of a blend of microencapsulated organic acids (OA, specifically citric and sorbic acid) and nature identical compounds (NIC, specifically thymol and vanillin), on growth, intestinal immune parameters and gut microbiota (GM) of European sea bass juveniles reared under normal and subsequently suboptimal environmental conditions (high temperature, 30.0 ± 0.4 °C and low oxygen, 4.6 ± 0.6 mg L-1). OA and NIC did not promote growth, feed utilisation and feed intake at the inclusion tested but induced a significantly upregulation of IL-8, IL-10 and TGFβ. GM analyzed by next-generation sequencing showed that OA and NIC were able to exert prebiotic properties stimulating the development of beneficial bacteria taxa such as Lactobacillus, Leuconostoc, and Bacillus sp. Picrust analyses displayed a significant potential functional reconfiguration of GM promoting a decrease in inflammation-promoting and homeostatic functions at increasing OA and NIC administration. For the first time on this species the exposure to suboptimal rearing conditions was able to modify GM structure reducing LAB and increasing Proteobacteria, findings which were consistent with the inflammatory process observed at mRNA level.Entities:
Mesh:
Substances:
Year: 2020 PMID: 33288837 PMCID: PMC7721706 DOI: 10.1038/s41598-020-78441-9
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Growth performance of European sea bass juveniles fed the experimental diets D0, D250, D500, D1000 calculated over 71 days (time range day 0–71) and at intermediate periods (time range day 0–37 and 37–71).
| Experimental diets | ||||
|---|---|---|---|---|
| D0 | D250 | D500 | D1000 | |
| Initial BW (g) | 13.32 ± 0.2 | 13.13 ± 0.0 | 13.23 ± 0.3 | 13.24 ± 0.1 |
| FBW (g) | 56.74 ± 2.24 | 56.80 ± 2.83 | 55.93 ± 3.21 | 56.18 ± 3.91 |
| SGR (% day−1) | 2.04 ± 0.06 | 2.06 ± 0.07 | 2.02 ± 0.05 | 2.03 ± 0.11 |
| FI (g kg ABW−1 day−1) | 18.52 ± 0.30 | 18.10 ± 0.45 | 18.17 ± 0.47 | 18.30 ± 0.21 |
| FCR | 1.05 ± 0.00 | 1.02 ± 0.00 | 1.03 ± 0.00 | 1.03 ± 0.02 |
| Survival% | 100 ± 0.00 | 100 ± 0.00 | 100 ± 0.00 | 100 ± 0.00 |
| Initial BW (g) | 13.30 ± 0.2 | 13.13 ± 0.0 | 13.23 ± 0.3 | 13.24 ± 0.1 |
| Intermediate BW (g) | 35.7 ± 1.39 | 34.80 ± 1.61 | 35.56 ± 2.91 | 35.17 ± 0.80 |
| SGR (% day−1) | 2.66 ± 0.08 | 2.63 ± 0.12 | 2.67 ± 0.16 | 2.64 ± 0.06 |
| FI (g kg ABW−1 day−1) | 24.79 ± 0.37 | 23.69 ± 0.50 | 23.84 ± 0.80 | 24.07 ± 0.98 |
| FCR | 1.01 ± 0.01 | 0.97 ± 0.03 | 0.97 ± 0.02 | 0.98 ± 0.02 |
| Survival% | 100 ± 0.00 | 100 ± 0.00 | 100 ± 0.00 | 100 ± 0.00 |
| Intermediate BW (g) | 35.7 ± 1.39 | 34.80 ± 1.61 | 35.56 ± 2.91 | 35.17 ± 0.80 |
| FBW (g) | 56.7 ± 2.24 | 56.8 ± 2.83 | 55.938 ± 3.21 | 56.2 ± 3.91 |
| SGR (%day−1) | 1.38 ± 0.12 | 1.45 ± 0.13 | 1.36 ± 0.07 | 1.41 ± 0.20 |
| FI (g kg ABW−1 day−1) | 15.06 ± 1.12 | 15.40 ± 0.88 | 14.91 ± 0.14 | 15.23 ± 0.95 |
| FCR | 1.11 ± 0.01 | 1.08 ± 0.04 | 1.12 ± 0.04 | 1.11 ± 0.09 |
| Survival% | 100 ± 0.00 | 100 ± 0.00 | 100 ± 0.00 | 100 ± 0.00 |
Data are given as the mean (n = 3) ± SD. No significant differences were detected (P > 0.05).
D dose blend (citric acid 25%, sorbic acid 16.7%, thymol 1.7%, vanillin 1%, matrix of hydrogenated fats) inclusion in diet, D0 0 ppm, D250 250 ppm, D500 500 ppm, D1000 1000 ppm, Initial BW initial body weight, Intermediate BW intermediate body weight, FBW final body weight, SGR specific growth rate (% day−1) = 100 × (ln FBW − ln IBW)/days, ABW average body weight = (IBW + FBW)/2, FI feed intake (g kg ABW−1 day−1) = ((1000 × total ingestion)/(ABW)/(days)), FCR feed conversion rate = feed intake/weight gain.
Biometric indices, whole body composition and nutritional indices of European sea bass fed the experimental diets D0, D250, D500, D1000 over 71 days.
| Experimental diets | ||||
|---|---|---|---|---|
| D0 | D250 | D500 | D1000 | |
| VSI | 12.2 ± 1.26 | 12.7 ± 1.99 | 12.4 ± 1.50 | 12.3 ± 1.50 |
| HSI | 2.84 ± 0.42 | 2.83 ± 0.41 | 2.75 ± 0.47 | 2.81 ± 0.43 |
| CF | 1.26 ± 0.08 | 1.22 ± 0.06 | 1.25 ± 0.10 | 1.27 ± 0.12 |
| Protein | 16.9 ± 0.6 | 16.3 ± 0.3 | 16 ± 0.3 | 16.5 ± 0.6 |
| Lipid | 17.6 ± 0.7 | 18.9 ± 0.3 | 18 ± 1.6 | 19.1 ± 0.7 |
| Ash | 3.68 ± 0.1 | 3.57 ± 0.5 | 3.51 ± 0.3 | 3.51 ± 0.1 |
| Moisture | 61.7 ± 0.3 | 60.4 ± 0.7 | 60.8 ± 1.6 | 60.6 ± 0.3 |
| PER | 1.89 ± 0.01 | 1.95 ± 0.01 | 1.92 ± 0.02 | 1.91 ± 0.05 |
| GPE | 31.9 ± 2.11 | 31.4 ± 0.87 | 30.1 ± 0.65 | 31.1 ± 0.77 |
| LER | 4.57 ± 0.02 | 4.71 ± 0.02 | 4.64 ± 0.04 | 4.61 ± 0.12 |
| GLE | 92.2 ± 4.04 | 102.3 ± 2.75 | 95.7 ± 8.31 | 101.7 ± 2.84 |
Biometric indices are given as the mean (n = 15) ± SD. No significant differences were detected (P > 0.05).
Whole body composition % are given as the mean (n = 3) ± SD.
Nutritional indices are given as the mean (n = 3) ± SD.
VSI Viscerosomatic index (%) = 100 × (viscera weight/FBW), HSI Hepatosomatic index (%) = 100 × (liver weight/FBW), CF Condition factor = 100 × (FBW/length3), PER Protein efficiency ratio = (FBW–IBW)/protein intake, GPE (%) Gross protein efficiency = 100 × [(% final body protein × FBW) − (% initial body protein × IBW)]/total protein intake fish, LER Lipid efficiency rate = (FBW − IBW)/lipid intake, GLE (%) Gross lipid efficiency = 100 × [(% final body lipid × FBW) − (% initial body lipid × IBW)]/total lipid intake fish.
Figure 1Linear regression analyses showing the effect of the dietary increasing level of OA and NIC on the relative expression of six cytokines genes (a–f) involved in the immune and inflammatory response at intestinal level at T1 (day 71).
Figure 2Two-way ANOVA analysis showing the expression of six cytokines genes (a–f) involved in the immune and inflammatory response in intestine among fish fed with D0 and D1000 diets at T1 (day 71) and T2 (after suboptimal rearing conditions).
Figure 3Autochthonous intestinal microbiota from sea bass Dicentrarchus labrax fed with control diet (D0) and different doses of microencapsulated OA and NIC (D250, D500 and D1000). (A) Average phylogenetic profiles of the gut microbiome of sea bass are provided at phylum (left) and genus (right) level; Phyla and genus which represent < 1.5% of the autochthonous community were included in ‘Others’. (B) Principal Component Analysis (PCA) of the Euclidean distance of sea bass gut microbial ecosystem after the assumption of different diets (D0, D250, D500 and D1000). A significant separation among groups was observed [P value = 0.03; Permutation test with pseudo-F ratios (Adonis)]. (C) Alpha diversity of the sea bass GM for all diet assumption was estimated with observed species and Shannon metrics.
Figure 4Profile of putative functions encoded by the sea bass gut microbial community during the diet intervention (D0, D250, D500, D1000). Principal Component Analysis (PCA) based on Euclidean distance between samples is reported in (A). A significant separation among groups was observed [P value = 0.04—Permutation test with pseudo-F ratios (Adonis)]. (B) D1000 promotes a significant decrease in several inflammation-promoting and homeostatic functions, such as bacterial invasion of epithelial cells (P = 0.01—Wilcoxon rank-sum test), bacterial toxins (P = 0.01—Wilcoxon rank-sum test) and mineral absorption (P = 0.02—Wilcoxon rank-sum test).
Figure 5Intestinal microbiota from sea bass Dicentrarchus labrax fed with D0 and D1000 diets before and after the suboptimal rearing condition. (A) Average phylogenetic profiles of the gut microbiome of sea bass are provided at phylum (left) and genus (right) level; Phyla and genus which represent < 1.5% of the autochthonous community were included in ‘Others’. (B) Alpha diversity of the sea bass GM for all diet assumption was estimated with observed species and Shannon metrics (yellow circle: supplemented, green circle: control). After the suboptimal rearing conditions, the GM of sea bass in both D0 and D1000 is characterized by a significant increase of diversity compared to normal conditions (P = 0.01; Wilcoxon rank-sum test).
Primer sequences used for gene expression analyses of immune genes.
| Gene | Abbreviation | GenBank ID | Primer sequence (5′–3′) | Amplicon (bp) | References |
|---|---|---|---|---|---|
| β-actin | β-act | AJ493428 | ACCCAGTCCTGCTCACAGAG CGGAGTCCATGACAATACCAGTG | 165 | This study |
| Interleukin 1 beta | IL-1β | AJ311925 | ATCTGGAGGTGGTGGACAAA AGGGTGCTGATGTTCAAACC | 106 | Sepulcre et al.[ |
| Interleukin 6 | IL-6 | AM490062 | ACTTCCAAAACATGCCCTGA CCGCTGGTCAGTCTAAGGAG | 170 | Sepulcre et al.[ |
| Interleukin 8 | IL-8 | AM490063 | GTCTGAGAAGCCTGGGAGTG GCAATGGGAGTTAGCAGGAA | 110 | Sepulcre et al.[ |
| Interleukin 10 | IL-10 | DQ821114 | CGACCAGCTCAAGAGTGATG AGAGGCTGCATGGTTTCTGT | 199 | Sepulcre et al.[ |
| Tumor necrosis factor alfa | TNF-α | DQ200910 | AGCCACAGGATCTGGAGCTA GTCCGCTTCTGTAGCTGTCC | 112 | Sepulcre et al.[ |
| Transforming growth factor beta | TGF-β | AM421619 | GACCTGGGATGGAAGTGGAT CAGCTGCTCCACCTTGTGTTG | 225 | Faliex et al.[ |